Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.045
-0.055 (-5.00%)
Apr 29, 2026, 12:01 PM EDT - Market open

Alzamend Neuro Cash Flow Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Jan '26 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2020 - 2016
Net Income
-7.04-4.51-9.95-14.88-12.36-5.05
Upgrade
Depreciation & Amortization
0.10.050.050.020-
Upgrade
Stock-Based Compensation
0.160.330.963.584.412.03
Upgrade
Other Operating Activities
-0.010-0.010.45
Upgrade
Change in Accounts Payable
1.22-2.290.051.710.69-0.41
Upgrade
Change in Other Net Operating Assets
-0.4-0.150.620.640.630.26
Upgrade
Operating Cash Flow
-5.96-6.57-8.27-8.92-6.61-2.71
Upgrade
Capital Expenditures
-0.21-0.3-0.15--0.11-
Upgrade
Other Investing Activities
-----0.1
Upgrade
Investing Cash Flow
-0.21-0.3-0.15--0.110.1
Upgrade
Short-Term Debt Issued
--0.3--2.25
Upgrade
Total Debt Issued
--0.3--2.25
Upgrade
Short-Term Debt Repaid
-----0.06-0
Upgrade
Total Debt Repaid
-----0.06-0
Upgrade
Net Debt Issued (Repaid)
--0.3--0.062.25
Upgrade
Issuance of Common Stock
0.842.71.25018.912.2
Upgrade
Financing Cash Flow
5.5210.443.65018.854.45
Upgrade
Net Cash Flow
-0.643.57-4.76-8.9212.131.84
Upgrade
Free Cash Flow
-6.17-6.87-8.42-8.92-6.72-2.71
Upgrade
Free Cash Flow Per Share
-2.45-15.24-111.97-123.53-101.83-50.40
Upgrade
Levered Free Cash Flow
-3.62-5.19-4.69-4.33-2.19-0.41
Upgrade
Unlevered Free Cash Flow
-3.61-5.17-4.68-4.33-2.16-0.31
Upgrade
Change in Working Capital
0.82-2.440.672.351.33-0.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.